Implementing Decentralized Clinical Trials in Australia through Teletrials: Where to From Here?

IF 2 4区医学 Q4 MEDICAL INFORMATICS

Therapeutic innovation & regulatory science Pub Date : 2024-04-29 DOI:10.1007/s43441-024-00658-x

Tanya Symons, Anne Woollett, John Zalcberg, Lisa Eckstein

引用次数: 0

Abstract

Implementation of decentralized approaches can improve access to clinical trials. The Australian government has focused on a teletrial model, which resources and upskills health care organisations to enable collaboration in trials to extend to rural and remote areas. This commentary describes the Australian teletrial model, its context within the established DCT model, its value, and likely challenges moving forward.

Abstract Image

查看原文本刊更多论文

在澳大利亚通过 Teletrials 实施分散临床试验：何去何从？

实施权力下放的方法可以提高临床试验的可及性。澳大利亚政府将重点放在了远程试验模式上，该模式为医疗机构提供资源并提高其技能，从而使试验合作扩展到农村和偏远地区。本评论介绍了澳大利亚的远程试验模式、其在既有 DCT 模式中的背景、价值以及未来可能面临的挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Therapeutic innovation & regulatory science MEDICAL INFORMATICS-PHARMACOLOGY & PHARMACY

CiteScore

3.40

自引率

13.30%

发文量

127

期刊介绍： Therapeutic Innovation & Regulatory Science (TIRS) is the official scientific journal of DIA that strives to advance medical product discovery, development, regulation, and use through the publication of peer-reviewed original and review articles, commentaries, and letters to the editor across the spectrum of converting biomedical science into practical solutions to advance human health. The focus areas of the journal are as follows: Biostatistics Clinical Trials Product Development and Innovation Global Perspectives Policy Regulatory Science Product Safety Special Populations